FR2100769A1 - - Google Patents

Info

Publication number
FR2100769A1
FR2100769A1 FR7121922A FR7121922A FR2100769A1 FR 2100769 A1 FR2100769 A1 FR 2100769A1 FR 7121922 A FR7121922 A FR 7121922A FR 7121922 A FR7121922 A FR 7121922A FR 2100769 A1 FR2100769 A1 FR 2100769A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7121922A
Other languages
French (fr)
Other versions
FR2100769B1 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck & Cie
Merck and Co Inc
Original Assignee
Merck & Cie
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Cie, Merck and Co Inc filed Critical Merck & Cie
Priority to FR7121922A priority Critical patent/FR2100769B1/fr
Publication of FR2100769A1 publication Critical patent/FR2100769A1/fr
Application granted granted Critical
Publication of FR2100769B1 publication Critical patent/FR2100769B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR7121922A 1971-06-16 1971-06-16 Expired FR2100769B1 (cg-RX-API-DMAC7.html)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7121922A FR2100769B1 (cg-RX-API-DMAC7.html) 1971-06-16 1971-06-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7121922A FR2100769B1 (cg-RX-API-DMAC7.html) 1971-06-16 1971-06-16

Publications (2)

Publication Number Publication Date
FR2100769A1 true FR2100769A1 (cg-RX-API-DMAC7.html) 1972-03-24
FR2100769B1 FR2100769B1 (cg-RX-API-DMAC7.html) 1974-09-27

Family

ID=9078781

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7121922A Expired FR2100769B1 (cg-RX-API-DMAC7.html) 1971-06-16 1971-06-16

Country Status (1)

Country Link
FR (1) FR2100769B1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2309233A1 (fr) * 1975-04-30 1976-11-26 Sankyo Co Derives de 7-methoxycephalosporine, leur procede de preparation et leurs applications
FR2486945A1 (fr) * 1980-07-15 1982-01-22 Ausonia Farma Srl Nouveaux derives de l'acide 1,3-thiazolidin-4-yl-carboxylique, leur procede de preparation et leur application en therapeutique

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2309233A1 (fr) * 1975-04-30 1976-11-26 Sankyo Co Derives de 7-methoxycephalosporine, leur procede de preparation et leurs applications
FR2486945A1 (fr) * 1980-07-15 1982-01-22 Ausonia Farma Srl Nouveaux derives de l'acide 1,3-thiazolidin-4-yl-carboxylique, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
FR2100769B1 (cg-RX-API-DMAC7.html) 1974-09-27

Similar Documents

Publication Publication Date Title
FI52477B (cg-RX-API-DMAC7.html)
CS167975B2 (cg-RX-API-DMAC7.html)
DK135437C (cg-RX-API-DMAC7.html)
DE2157778A1 (cg-RX-API-DMAC7.html)
CS167541B1 (cg-RX-API-DMAC7.html)
DE2144151A1 (cg-RX-API-DMAC7.html)
CS162921B1 (cg-RX-API-DMAC7.html)
FR2095147A7 (cg-RX-API-DMAC7.html)
CS161949B2 (cg-RX-API-DMAC7.html)
CS156246B1 (cg-RX-API-DMAC7.html)
FR2083184A5 (cg-RX-API-DMAC7.html)
FR2109998A6 (cg-RX-API-DMAC7.html)
AU2455871A (cg-RX-API-DMAC7.html)
CS152162B1 (cg-RX-API-DMAC7.html)
CS149883B1 (cg-RX-API-DMAC7.html)
CS165281B1 (cg-RX-API-DMAC7.html)
DE2103798A1 (cg-RX-API-DMAC7.html)
DE2120538A1 (cg-RX-API-DMAC7.html)
CS168860B1 (cg-RX-API-DMAC7.html)
DE2127006A1 (cg-RX-API-DMAC7.html)
CS149058B1 (cg-RX-API-DMAC7.html)
DE2132413A1 (cg-RX-API-DMAC7.html)
CS149180B1 (cg-RX-API-DMAC7.html)
DE2109364A1 (cg-RX-API-DMAC7.html)
CS149117B1 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
CC Supplementary certificate of protection laid open to the public (law of 25 june 1990)

Free format text: 92C0397, 920604

CB Supplementary certificate of protection granted (law of 25 june 1990)

Free format text: 92C0397, 710616

CL Concession to grant licenses